Relationship between polymorphisms of CXCL3 gene and preeclampsia

References

• Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56–59.
   PubMed Web of Science ®Google Scholar
• Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497–506.
   PubMed Web of Science ®Google Scholar
• Souza JP, Gülmezoglu AM, Vogel J, et al. Moving beyond essential interventions for reduction of maternal mortality (the who multicountry survey on maternal and newborn health): a cross-sectional study. Lancet. 2013;381(9879):1747–1755.
   PubMed Web of Science ®Google Scholar
• Kajantie E, Osmond C, Eriksson JG. Gestational hypertension is associated with increased risk of type 2 diabetes in adult offspring: the Helsinki birth cohort study. Am J Obstet Gynecol. 2017;216(3):281.e1–281.e7.
   Web of Science ®Google Scholar
• Chen H, Zhang Y, Dai L, et al. Association between polymorphisms in CXCR2 gene and preeclampsia. Mol Genet Genomic Med. 2019;7(4):e00578.
   PubMed Web of Science ®Google Scholar
• Furuichi K, Wada T, Yokoyama H, et al. Role of cytokines and chemokines in renal ischemia-reperfusion injury. Drug News Perspect. 2002;15(8):477–482.
   PubMedGoogle Scholar
• Tsou PS, Rabquer BJ, Ohara RA, et al. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines. Rheumatology (Oxford). 2016;55(4):745–754.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang T, Dai L, et al. Effects of CXCL3 on migration, invasion, proliferation and tube formation of trophoblast cells. Placenta. 2018;66:47–56.
   PubMed Web of Science ®Google Scholar
• Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Preg Hypertension. 2018;13:291–310.
   PubMed Web of Science ®Google Scholar
• Von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Preg Hypertens. 2003;22(2):143–148.
   Web of Science ®Google Scholar
• Solé X, Guinó E, Valls J, et al. Snpstats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928–1929.
   PubMed Web of Science ®Google Scholar
• Gui SL, Teng LC, Wang SQ, et al. Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer. Int Urol Nephrol. 2016;48(5):701–709.
   PubMed Web of Science ®Google Scholar
• Rios DRA, Alpoim PN, Godoi LC, et al. Increased levels of sENG and sVCAM-1 and decreased levels of VEGF in severe preeclampsia. AJHYPE. 2016;29(11):1307–1310.
   PubMed Web of Science ®Google Scholar
• Redman CW, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213((4)(Suppl):S9–S11.
   PubMed Web of Science ®Google Scholar
• Mckeeman GC, Ardill JES, Caldwell CM, et al. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004;191(4):1240–1246.
   PubMed Web of Science ®Google Scholar
• Karumanchi SA. Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension. 2016;67(6):1072–1079.
   PubMed Web of Science ®Google Scholar
• Buurma AJ, Turner RJ, Driessen JHM, et al. Genetic variants in pre-eclampsia: a meta-analysis. Hum Reprod Update. 2013;19(3):289–303.
   PubMed Web of Science ®Google Scholar
• Amanda LPS, Kuan Chong P, Lu SY, et al. CXCL3 is a potential target for breast cancer metastasis. Curr Cancer Drug Targets. 2014;14(3):294–309.
   PubMed Web of Science ®Google Scholar
• Subimerb C, Wongkham C, Khuntikeo N, et al. Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome. Asian Pac J Cancer Prev. 2014;15(10):4217–4224.
   PubMedGoogle Scholar
• Kogan-Sakin I, Cohen M, Paland N, et al. Prostate stromal cells produce cxcl-1, cxcl-2, cxcl-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis. 2009;30(4):698–705.
   PubMed Web of Science ®Google Scholar
• Payne AS, Cornelius LA. The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol. 2002;118(6):915–922.
   PubMed Web of Science ®Google Scholar
• Russo RC, Garcia CC, Teixeira MM, et al. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(5):593–619.
   PubMed Web of Science ®Google Scholar
• Rebollo J, Geliebter J, Reyes N. ESM-1 siRNA knockdown decreased migration and expression of CXCL3 in prostate cancer cells. Int J Biomed Sci. 2017;13(1):35–42.
   PubMedGoogle Scholar
• Delahanty RJ, Xiang YB, Spurdle A, et al. Polymorphisms in inflammation pathway genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2013;22(2):216–223.
   PubMed Web of Science ®Google Scholar
• Tomppo L, Ekelund J, Lichtermann D, et al. Disc1 conditioned GWAS for psychosis proneness in a large Finnish birth cohort. PLoS One. 2012;7(2):e30643.
   PubMed Web of Science ®Google Scholar
• Zhang N, Mchale LK, Finer JJ. A leader intron of a soybean elongation factor 1a (eEF1a) gene interacts with proximal promoter elements to regulate gene expression in synthetic promoters. PLoS One. 2016;11(11):e0166074.
   PubMed Web of Science ®Google Scholar
• Ikeda T, Sun L, Tsuruoka N, et al. Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing. Biochem J. 2011;436(2):399–407.
   PubMedGoogle Scholar
• Saarela T, Hiltunen M, Helisalmi S, et al. Adiponectin gene haplotype is associated with preeclampsia. Genet Test. 2006;10(1):35–39.
   PubMedGoogle Scholar
• Lopes DS, Cristina A. Association among ACE, ESR1 Polymorphisms and Preeclampsia in Brazilian pregnant women. Mol Cell Probes. 2019;45:43–47.
   PubMed Web of Science ®Google Scholar
• Goldman-Wohl D, Yagel S. Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol. 2002;187(1-2):233–238.
   PubMed Web of Science ®Google Scholar
• Gui S, Ni S, Jia J, et al. Inconformity of CXCL3 plasma level and placenta expression in preeclampsia and its effect on trophoblast viability and invasion. PLoS One. 2014;9(12):e114408.
   PubMed Web of Science ®Google Scholar